Special Issue "Antimicrobial Agents"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (31 July 2013)

Special Issue Editor

Guest Editor
Dr. D. Andrew Knight
Chemistry Department, Florida Institute of Technology, 150 West University Boulevard, Melbourne, FL 32901, USA
Website: http://cos.fit.edu/chemistry/faculty/knight
E-Mail: aknight@fit.edu
Interests: catalysis and organic synthesis; nanoscale and layered materials; medicinal chemistry; molecular biology; biodefense and green chemistry

Special Issue Information

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 800 CHF (Swiss Francs).

Published Papers (6 papers)

by , , ,  and
Pharmaceuticals 2013, 6(12), 1451-1474; doi:10.3390/ph6121451
Received: 22 September 2013; in revised form: 29 October 2013 / Accepted: 8 November 2013 / Published: 25 November 2013
Show/Hide Abstract | PDF Full-text (252 KB) | HTML Full-text | XML Full-text

by  and
Pharmaceuticals 2013, 6(11), 1381-1406; doi:10.3390/ph6111381
Received: 21 July 2013; in revised form: 22 October 2013 / Accepted: 30 October 2013 / Published: 7 November 2013
Show/Hide Abstract | PDF Full-text (206 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Pharmaceuticals 2013, 6(11), 1335-1346; doi:10.3390/ph6111335
Received: 29 September 2013; in revised form: 26 October 2013 / Accepted: 28 October 2013 / Published: 1 November 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (566 KB) | HTML Full-text | XML Full-text

by , , ,  and
Pharmaceuticals 2013, 6(9), 1130-1144; doi:10.3390/ph6091130
Received: 30 July 2013; in revised form: 26 August 2013 / Accepted: 2 September 2013 / Published: 6 September 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (346 KB) | HTML Full-text | XML Full-text

by  and
Pharmaceuticals 2013, 6(8), 1055-1081; doi:10.3390/ph6081055
Received: 16 July 2013; in revised form: 2 August 2013 / Accepted: 16 August 2013 / Published: 21 August 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (1019 KB) | HTML Full-text | XML Full-text

by , , , , , , , , ,  and
Pharmaceuticals 2013, 6(7), 837-850; doi:10.3390/ph6070837
Received: 22 April 2013; in revised form: 14 May 2013 / Accepted: 17 June 2013 / Published: 1 July 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (428 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 19 December 2012

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert